Navigation Links
Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
Date:12/13/2012

MIAMI, Dec. 13, 2012 /PRNewswire/ -- Insero Health, Inc., a company developing natural compounds to address unmet medical needs in neurological disorders, today announced that it has completed a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy.  Insero also reported that two key US patents licensed from Harvard University have issued, and the company announced the formation of its Scientific Advisory Board (SAB).

INS001, also known as huperzine A, is a naturally-occurring compound that has shown promising activity in preclinical epilepsy models.  It has previously demonstrated good safety and signs of therapeutic activity in a Phase II trial in Alzheimer's disease and in preclinical models of multiple sclerosis and neuropathic pain.

The Phase lb epilepsy trial included dose ranging assessments, as well as biomarkers chosen to provide information on the potential therapeutic activity and cardioprotective properties of INS001.  Insero expects to report the results of the Phase Ib trial in the next few months and to initiate Phase II proof-of-principle trials by early 2014.

Epilepsy affects about three million people in the United States and over 50 million people worldwide. Many people with epilepsy take multiple medications, yet the published literature suggests that as many as one-third are unable to control their seizures with current therapy.  INS001 has a unique mechanism of action, which suggests it may provide superior efficacy either as a stand-alone therapy or when given in combination with other epilepsy drugs.

The two newly-issued patents were exclusively licensed to Insero by Harvard University and cover the use of INS001 as a treatment for epilepsy and other indications.  The company also has licensed technology patents from Yale University and the University of South Florida.  In addition, Insero is continuing its research programs related to its library
'/>"/>

SOURCE Insero Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
3. BodyMedia Collaborates on Federal Health Research Study
4. AssureRx Health Expands Management Team to Support Increasing Business Growth
5. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
6. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
7. STATEMENT OF CHAIRMAN AND CEO GEORGE BARRETT FORTUNE 21 CARDINAL HEALTH REGARDING FISCAL CLIFF
8. inVentiv Health Strengthens Clinical Leadership Team
9. USANA True Health Foundation: Musician Donates Proceeds Of Holiday Song To Charity
10. Henry Schein To Present At The Oppenheimer 23rd Annual Healthcare Conference
11. Health Outcomes Liaisons Key to Pharmaceutical Sector Navigating Payer-Focused Marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), ... equipment for all forms of sports, including extreme motor ... brace, announced today that the UISP Lega Motociclismo Lombardia, ... all riders to wear a neck brace during its ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... N.J., May 26, 2011 Johnson & Johnson (NYSE: ... its Pharmaceuticals business at a meeting with the investment ... and pharmaceuticals segment will review how the business plans ... needs and outpace pharmaceutical market growth with an optimized ...
... Pharmaceuticals, Inc. (NASDAQ: AMLN ) ("Amylin" or "the ... the Southern District of California issued a temporary restraining order ... ) ("Lilly") relating to its litigation with respect to the ... District Court restrained Lilly from proceeding with its plans to ...
Cached Medicine Technology:Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 2Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 3Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 4Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 5Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 2Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 3Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 4
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 As interest ... overall health care gains momentum worldwide, Rev. Eric J. ... HealthCare Chaplaincy Network (HCCN), will be the keynote speaker ... care in Israel’s public health system. , The conference, “Hope ...
(Date:1/22/2015)... 2015 Compare-autoinsurance.org has released a new blog post ... auto insurance policy . , Some types of vehicles ... check the newly released blog post to see if their vehicle ... damaged vehicles are some of the cars that cannot be covered ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 26, 2014 The US represents the largest ... In 2013, GlobalData’s forecast estimates that sales of branded therapies ... due to the high incidence of the disease, high drug ... Japan, and China. Increased sales of CRC therapies over the ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Virtual Radiologic,Corporation (Nasdaq: VRAD ) today announced the ... common stock at a price of $17.00,per share. All ... offering, certain selling stockholders granted the underwriters a,30-day option ... at the,initial public offering price. Virtual Radiologic intends ...
... following is a,statement from Jeff Levi, Executive Director ... America,s Health (TFAH) urges Congress to override the,President,s ... Education and,Related Agencies Appropriations bill., The Labor/HHS ... -- Assist states, territories, localities and hospitals to ...
... DDD; OTCBB: DRUG; BBSE: DRP) today announced that it ... sale of its EPO business which,accounted for less than ... of 2007. The decision was made based on the ... if not downward trend, during,the next three years. The ...
... Thanksgiving meal preparation turns,the common kitchen into a ... boards. But despite all of that, it doesn,t have ... cooks pay attention to one,cooking coach,s advice. Listen ... http://media.medialink.com/WebNR.aspx?story=34114 Registered journalists can access video, audio, ...
... help for Minnesotans looking to quit ... ... will take place on Thursday, November 15. Begun in Monticello,Minnesota, and now ... using tobacco for at least one day. "The Great American Smokeout ...
... is first to extend survival for those resistant to ... -- A highly targeted biologic drug called cetuximab (Erbitux) ... with advanced colon cancer who have otherwise proved resistant ... drug, which costs $12,000 a month in the United ...
Cached Medicine News:Health News:Virtual Radiologic Corporation Announces Pricing of Initial Public Offering 2Health News:Dragon Sells EPO Business; Focus on Antibiotic Core Business 2Health News:ClearWay Minnesota(SM) to Share Stories of Real Minnesotans Who Used QUITPLAN(R) Services During Great American Smokeout 2Health News:Drug Helps Fight Late-Stage Colon Cancer in Some Patients 2Health News:Drug Helps Fight Late-Stage Colon Cancer in Some Patients 3Health News:Drug Helps Fight Late-Stage Colon Cancer in Some Patients 4
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... 10% Povidone Iodine USP, 1% available Iodine, ... prep, Povidone Iodine Gel helps to minimize ... patient, thus reducing the chance of patient ... a one step gel for venipuncture site ...
... Gel is a viscous antimicrobial that contains ... for broad-spectrum germicidal action. As a preoperative ... minimize the pooling of prepping solutions under ... patient burns. Povidone Iodine Topical Gel is ...
... Povidone Iodine Prep Solution is appropriate ... paint, wet soak or spray); disinfecting ... antiseptic treatment of lacerations and abrasions. ... anti-infective agent in hospital and office ...
Medicine Products: